Grifols Partnership stands out from other CDMOs through our commitment to the well-being of patients and their quality of life. Safety is elevated above regulatory obligation and is coupled with our holistic approach to quality. This Grifols philosophy encompasses not just our products, but also permeates our internal manufacturing, communication, and operational procedures.
Our commitment to quality has engendered a robust, dependable quality system, establishing Grifols Partnership as an ideal strategic partner.
We manufacture our products to stringent GMP standards and the requirements of the US and European Pharmacopeia, targeting excellence in the finished product.
The production of sterile parenteral products requires not only a culture of quality, but effective quality systems to consistently meet the highest safety standards. Our culture of quality is reflected in our commitment to continuous improvement, and underscored by our integration of quality into manufacturing processes from the outset.
Adhering to a quality-by-design (QbD) methodology and complying with parametric release requisites stand as two pillars of a successful and effective quality program.
While safety and quality are central to everything we do, our partners also demand efficiency. Our innovative manufacturing processes substitute inefficient manual operations with extensively automated, multifaceted processes which elevate quality and increase productivity.
We work diligently to ensure the highest levels of quality in our production processes. A team of more than 60 professionals at our sites manages quality control activities through the Quality Control Area.
We continually enhance our quality systems, earning top accreditations and certifications. Grifols secured AEMPS authorization for parametric release of parenteral solutions in glass and flexible containers at our Spanish manufacturing plants, making us a European pioneer in this achievement.
Parametric release ensures product quality through data collected during manufacturing, complying with good manufacturing practices. Our rigorous quality system at Laboratorios Grifols earned us this recognition, guaranteeing product sterility without additional sterility tests.
Safety isn't just regulation, it's our philosophy at Grifols. It applies to our products and internal processes, from manufacturing to communication.
Grifols Partnership exemplifies the advantages of vertical integration with form-fill-seal technology. This automated process creates polypropylene containers (bags) by forming, filling, and sealing them in a single step, free from human interaction. Grifols manufactures components like ports and stoppers, and employs equipment developed by Grifols Engineering to ensure complete control.
Grifols Engineering, a subsidiary of Grifols, designs pharmaceutical production facilities, processes, and machinery for Grifols and other pharmaceutical manufacturers. As part of a pharmaceutical company, it possesses deep knowledge of quality and compliance requirements for pharmaceutical production and facility design.
Through vertical integration, Grifols maintains end-to-end control, ensuring uniform high-quality standards throughout the manufacturing process. This dedication to quality extends across all company activities.
Grifols is a leader in the Spanish pharmaceutical market for large volume parenteral solutions. The company has over 100 years of experience in the parenteral solutions field.
Experts in development and contract manufacturing (CDMO), with long-standing satisfied customers.
Experts in formulation, filling, terminal sterilization, labelling and packaging in flexible container (PP bags) and vials.
Sterile Manufacturing Solutions
Parenteral Delivery Systems
Grifols' history reflects a team that has grown with new members joining our project. While some contributions to the team are particularly decisive, the final outcome results from the cooperation and teamwork of everyone at Grifols.
We take pride in being part of a company where honesty guides decision making, and where we each contribute to Grifols' reputation in society.
Oriol Prat
Director Contract Manufacturing &
IV Solutions
Marga Viñes
Senior Business Development Manager
Contract Manufacturing
Estela Llorens
Director of Research & Development
Marta Serra
Technical Director Laboratorios Grifols
Ricardo Bernabé
Director of Manufacturing Murcia Facility
Oriol Argemí
Managing Director Laaboratorios Grifols
Lluc Mercadé
Director of Manufacturing Facility in
Parets del Vallés
Àngels Romero
Director of Finance Laboratorios Grifols
Carla Mössinger
Business Development Manager
Contract Manufacturing
Grifols Partnership actively pursues projects with small, big, and emerging pharma companies, spanning human and veterinary markets, both globally and domestically.
Successful project completion hinges on aligning commercial strategies between organizations which is why we provide integrated project management for product development and supply.
Our team includes experts from all relevant areas who implement new processes and products at manufacturing sites. We meticulously plan and track each project, ensuring you are informed every step of the way.
We understand that what works for one company may not suit another. We are solutions focussed, providing insights into how process or product design changes can affect final product acceptance.
This knowledge is valuable for drug manufacturers looking to distinguish their small molecule parenteral products, whether introducing a new branded therapy in a glass vial or extending the life cycle of a generic premixed solution in flexible plastic packaging.
Pharmaceutical and Analytical Development
Scale-up, Engineering and Registration batches
Commercial Manufacturing
As outlined above, we oversee every process step, including regulatory compliance. Grifols Partnership includes regulatory support in our sterile contract manufacturing solutions, supplying customers with technical documentation, safety sheets, and certificates of analysis for registration in selected markets.